NGENLA (somatrogon) 24 mg / 72IU is a modern long-acting human growth hormone pen engineered by Pfizer using advanced recombinant biotechnology. The formulation is designed to extend the biological activity of HGH, enabling less frequent injections compared to traditional daily somatropin products.

Each NGENLA pen contains a freeze-dried formulation that, once reconstituted, provides a smooth and consistent administration profile. The pen format is crafted to enhance ease of handling, allow controlled delivery, and support users who prefer structured dosing convenience.

NGENLA mimics the structure and activity of naturally produced human growth hormone and is valued for its extended-release characteristics and predictable performance under professional supervision.

⭐ Key Benefits of NGENLA 24 mg / 72IU

• Long-acting HGH formulation — designed for reduced injection frequency
• Pfizer-engineered biosynthetic somatropin — high stability and consistent purity
• Pre-measured pen format — clear dosing control and simplified use
• Smooth reconstitution process — lyophilized for stability
• Predictable release profile — gradual hormone availability post-injection
• Ideal for structured, supervised hormone management

🔬 How NGENLA Works in the Body

HGH plays a role in:

• Maintaining lean body mass
• Supporting normal metabolic processes
• Aiding tissue renewal and cellular repair
• Regulating nutrient utilisation
• Enhancing overall physical recovery and vitality

NGENLA’s extended-release mechanism helps maintain more stable somatropin levels over longer intervals.

📦 Packaging & Contents

• 1 pen × 24 mg / 72IU somatropin
• Lyophilized formulation inside sealed Pfizer pen
• Designed for reconstitution prior to use
• Compatible with standard disposable pen needles

⚠️ Usage Notes & Storage

• Use only under the guidance of a qualified professional
• Store refrigerated as per Pfizer guidelines
• After reconstitution, keep refrigerated and avoid exposure to heat/light
• Do not freeze the product